SOPHiA GENETICS S.A.
SOPHiA GENETICS S.A. (SOPH) Stock Overview
Explore SOPHiA GENETICS S.A.’s financial performance, market position, analyst ratings, and future outlook.
Key Financials
Key Financials
Market Cap
312.8M
P/E Ratio
-4.01
EPS (TTM)
$-1.17
ROE
-1.17%
SOPH Stock Analysis & Investment Overview
Our comprehensive AI-powered analysis of SOPHiA GENETICS S.A. (SOPH) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.
The current technical analysis reveals key indicators including an RSI of 49.55, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $5.64.
Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -4.01 and a market capitalization of 312.8M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.